Rapid Deployment Vaccine Collaborative (RaDVaC) Revenue and Competitors

Our mission is rapid development, testing, and public sharing of vaccine recipes that are simple enough to be produced and administered by individual citizen scientists. Beginning early in the 2020 pandemic, we designed, produced, and self-administered several progressive generations of nasal vaccines against SARS-CoV-2. As of late July, 2020, over twenty of us have self-adminstered the vaccine. We have not filed any patents or other intellectual property protections, and all information on our vaccine designs, material procurement, production, self-administration, and testing are freely shared on this website. In addition to publicly releasing the results of our vaccine work, we are working with other researchers to advance new kinds of testing to assess immunity. We hope to motivate others around the world to build on our efforts, to share their research openly, and to deploy vaccines rapidly and safely.